CT7001 hydrochloride is primarily utilized in the field of medical research, particularly in the study of cancer therapies. It functions as a potent and selective inhibitor of Aurora kinases, which are involved in cell cycle regulation. By targeting these kinases, it helps in understanding the mechanisms of cell proliferation and apoptosis, which are crucial in cancer biology. This compound is often used in preclinical studies to evaluate its efficacy and safety in inhibiting tumor growth, making it a valuable tool in the development of new anticancer drugs. Additionally, its role in kinase inhibition also extends to research in other diseases where kinase activity is dysregulated, providing insights into potential therapeutic strategies.